Epichem achieves ISO 90001-2015 certification
161016_EPICHEM ACHIEVES ISO 9001-2015 CERTIFICATION
MPL capsules shipped to centres in NSW & Qld for Phase II
161013_MPL capsules shipped to centres in NSW & Qld for Phase II
PharmAust Investor Presentation – June 2016
160829_PharmAust Investor Presentation – June 2016
Further Canine Trials to be Initiated in Australia
160810_Further Canine Trials to be Initiated in Australia
IP exchange with UNSW consolidates MPL patent position
160803_IP exchange with UNSW consolidates MPL patent position
Reformulated MPL capsules completed, Phase II to commence
160711_Reformulated MPL capsules completed, Phase II to commence
Appendix 4E Annual Report & Full Year Statutory Accounts 2016
160831_Appendix 4E Annual Report & Full Year Statutory Accounts 2016
Appendix 4G & Corporate Governance Statement
160831_Appendix 4G & Corporate Governance Statement
University of Cambridge to begin Phase II Trial
160627_University of Cambridge to begin Phase II Trial
Epichem Successful in AusTrade Grant
160616_ Epichem Successful in AusTrade Grant